371 related articles for article (PubMed ID: 11023978)
1. ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex.
Bienengraeber M; Alekseev AE; Abraham MR; Carrasco AJ; Moreau C; Vivaudou M; Dzeja PP; Terzic A
FASEB J; 2000 Oct; 14(13):1943-52. PubMed ID: 11023978
[TBL] [Abstract][Full Text] [Related]
2. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
Hambrock A; Löffler-Walz C; Kloor D; Delabar U; Horio Y; Kurachi Y; Quast U
Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
[TBL] [Abstract][Full Text] [Related]
3. Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance.
Zingman LV; Alekseev AE; Bienengraeber M; Hodgson D; Karger AB; Dzeja PP; Terzic A
Neuron; 2001 Aug; 31(2):233-45. PubMed ID: 11502255
[TBL] [Abstract][Full Text] [Related]
4. Tandem function of nucleotide binding domains confers competence to sulfonylurea receptor in gating ATP-sensitive K+ channels.
Zingman LV; Hodgson DM; Bienengraeber M; Karger AB; Kathmann EC; Alekseev AE; Terzic A
J Biol Chem; 2002 Apr; 277(16):14206-10. PubMed ID: 11825892
[TBL] [Abstract][Full Text] [Related]
5. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.
Hosy E; Dérand R; Revilloud J; Vivaudou M
J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180
[TBL] [Abstract][Full Text] [Related]
6. Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity.
Park S; Lim BB; Perez-Terzic C; Mer G; Terzic A
J Proteome Res; 2008 Apr; 7(4):1721-8. PubMed ID: 18311911
[TBL] [Abstract][Full Text] [Related]
7. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
8. Mutation in nucleotide-binding domains of sulfonylurea receptor 2 evokes Na-ATP-dependent activation of ATP-sensitive K+ channels: implication for dimerization of nucleotide-binding domains to induce channel opening.
Yamada M; Ishii M; Hibino H; Kurachi Y
Mol Pharmacol; 2004 Oct; 66(4):807-16. PubMed ID: 15258252
[TBL] [Abstract][Full Text] [Related]
9. Altered functional properties of KATP channel conferred by a novel splice variant of SUR1.
Sakura H; Trapp S; Liss B; Ashcroft FM
J Physiol; 1999 Dec; 521 Pt 2(Pt 2):337-50. PubMed ID: 10581306
[TBL] [Abstract][Full Text] [Related]
10. A functional role of the C-terminal 42 amino acids of SUR2A and SUR2B in the physiology and pharmacology of cardiovascular ATP-sensitive K(+) channels.
Yamada M; Kurachi Y
J Mol Cell Cardiol; 2005 Jul; 39(1):1-6. PubMed ID: 15978900
[TBL] [Abstract][Full Text] [Related]
11. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
12. C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.
Matsuoka T; Matsushita K; Katayama Y; Fujita A; Inageda K; Tanemoto M; Inanobe A; Yamashita S; Matsuzawa Y; Kurachi Y
Circ Res; 2000 Nov; 87(10):873-80. PubMed ID: 11073882
[TBL] [Abstract][Full Text] [Related]
13. [Activation of ATP-sensitive K+ channels by ADP and K+ channel openers: homology model of sulfonylurea receptor carboxyl-termini].
Fujita A; Matsuoka T; Matsushita K; Kurachi Y
Nihon Yakurigaku Zasshi; 2001 Sep; 118(3):177-86. PubMed ID: 11577458
[TBL] [Abstract][Full Text] [Related]
14. KATP channel openers: structure-activity relationships and therapeutic potential.
Mannhold R
Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
[TBL] [Abstract][Full Text] [Related]
15. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
[TBL] [Abstract][Full Text] [Related]
16. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
de Wet H; Rees MG; Shimomura K; Aittoniemi J; Patch AM; Flanagan SE; Ellard S; Hattersley AT; Sansom MS; Ashcroft FM
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18988-92. PubMed ID: 18025464
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A KATP channels: a mechanistic study.
Proks P; de Wet H; Ashcroft FM
J Gen Physiol; 2014 Nov; 144(5):469-86. PubMed ID: 25348414
[TBL] [Abstract][Full Text] [Related]
18. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
19. NMR and fluorescence studies of drug binding to the first nucleotide binding domain of SUR2A.
López-Alonso JP; de Araujo ED; Kanelis V
Biochemistry; 2012 Nov; 51(45):9211-22. PubMed ID: 23078514
[TBL] [Abstract][Full Text] [Related]
20. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
